Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of an anti-obesity compound to individuals with renal impairment

Administration of an anti-obesity compound to individuals with renal impairment

US Patent 8999970 · Granted Apr 7, 2015

Estimated economic value: $22,841,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating conditions related to the S1P1 receptor2025
Methods of treating conditions related to the S1P1 receptor2024
Methods of treating conditions related to the S1P1 receptor2021
Administration of an anti-obesity compound to individuals with renal impairment2017
Administration of an anti-obesity compound to individuals with renal impairment2017
Method of weight management2015
Use of exendin and analogs thereof to delay or prevent cardiac remodeling2015
Modulation of STAT 6 expression2013
Methods of treating obesity with two different anti-obesity agents2013
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2006
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2005
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2005